Why Should Investors Pay Attention To This AI Powerhouse
Workiva built its name on simplifying complexity. Its platform acts as a connective layer between dozens of disconnected business tools, from Excel and SAP to cloud databases, bringing them together into one cohesive workspace.
Think of it as a control tower for enterprise reporting, where data flows seamlessly instead of being manually copied and pasted across spreadsheets and systems.
» Read more about: Why Should Investors Pay Attention To This AI Powerhouse »
Read More
Costco’s Secret Profit Engine
Beneath the surface, Costco isn’t just about cheap gas, hot dogs, and fancy electronics, but the financial engine is far less obvious, and far more powerful than most casual shoppers realize.
If you’re thinking about buying Costco stock, understanding these three fundamentals could change how you see the company’s long-term investment case.
Key Points
-
Annual fees generate the majority of net income,
» Read more about: Costco’s Secret Profit Engine »
Read More
Why Novo May Be the Real Winner in Obesity Drug Boom
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »
Read More
1 Stock to Own for the Next Decade
Every once in a while, a company comes along that feels like the rare exception, a business so well-positioned, diversified, and forward-looking that it could anchor a portfolio for years.
Broadcom is one of those companies and it might be the single best position to hold for the foreseeable future.
Key Points
-
Broadcom combines cyclical chip sales with high-margin recurring software revenue from acquisitions like CA,
» Read more about: 1 Stock to Own for the Next Decade »
Read More
Why Novo May Be the Real Winner in Obesity Drug Boom
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »
Read MoreThe Burst
The Future of Technology In 2026 and Beyond
Over the past decade, the tech sector has tended to rebound after bouts of underperformance, about 80% of the time, historically. This year looked like another chapter in that same story: short-term skepticism giving way to renewed conviction.
Now, as we move into the final quarter of 2025, several massive forces are quietly re-shaping the landscape.
» Read more about: The Future of Technology In 2026 and Beyond »
Read MoreThe Ivy
Which AI Stock Is Best?
Over the past year, CoreWeave (NASDAQ: CRWV) and Nebius (NASDAQ: NBIS) have become two of the hottest names in AI infrastructure.
Both run massive GPU cloud platforms that power artificial intelligence training and inference workloads, and both stocks have exploded. CoreWeave is up more than 230%, while Nebius has surged over 500%.
» Read more about: Which AI Stock Is Best? »
Read MoreThe Daily
This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?
Key Points
-
Veeva Systems markets a suite of software services geared toward the biopharmaceutical industry.
-
A wholly owned customer relationship management service is gaining steam for Veeva Systems.